Woodline Partners’s Chemed CHE Stock Holding History

Woodline Partners’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-58,178	Closed	-$35.8M	–	938
2025 Q1	$35.8M	Buy	58,178 +56,086	+2,681%	+$31.9M	0.23%	134
2024 Q4	$1.11M	Sell	2,092 -35,513	-94%	-$20M	0.01%	740
2024 Q3	$22.6M	Buy	+37,605	New	+$21.3M	0.19%	176
2023 Q2	–	Sell	-45,211	Closed	-$24.3M	–	652
2023 Q1	$24.3M	Buy	45,211 +2,379	+6%	+$1.21M	0.33%	90
2022 Q4	$21.9M	Buy	+42,832	New	+$20.8M	0.29%	94
2022 Q3	–	Sell	-1,020	Closed	-$479K	–	762
2022 Q2	$479K	Buy	+1,020	New	+$498K	0.01%	571
2022 Q1	–	Sell	-20,949	Closed	-$11.1M	–	739
2021 Q4	$11.1M	Buy	20,949 +1,000	+5%	+$480K	0.16%	180
2021 Q3	$9.28M	Sell	19,949 -12,260	-38%	-$5.78M	0.15%	173
2021 Q2	$15.3M	Buy	+32,209	New	+$15.5M	0.29%	94

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Woodline Partners's CHE Position: Q2 2025 in Review

Woodline Partners sold out of Chemed (CHE) in Q2 2025, closing a stake of 58,178 shares — an estimated $35.8M sold.

Woodline Partners first reported a position in CHE in Q2 2021 and held it in 9 quarters. The position peaked at $35.8M in Q1 2025. 537 funds tracked by Wall St. Rank hold CHE as of Q2 2025.

Woodline Partners reported no remaining Chemed position as of Q2 2025 after selling out during the quarter.
Woodline Partners sold 58,178 Chemed shares in Q2 2025, an estimated $35.8M.
Woodline Partners first reported a position in Chemed in Q2 2021 and held it in 9 quarters.
Woodline Partners's Chemed position peaked at $35.8M in Q1 2025.
537 funds tracked by Wall St. Rank held Chemed as of Q2 2025.

Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.